Related Experiment Videos
Novel signaling pathways contributing to vascular changes in hypertension
D G Johns1, A M Dorrance, R Leite
1Department of Physiology, Medical College of Georgia, Augusta, GA 30912-3000, USA.
Journal of Biomedical Science
|November 4, 2000
Summary
Hypertension involves abnormal blood vessel responses and remodeling. This review explores four cell signaling pathways—EGFR, sphingolipids, Rho/Rho kinase, and microtubules—offering new targets for treating high blood pressure.
Area of Science:
- Cardiovascular Biology
- Cellular Signaling
- Hypertension Research
Background:
- Hypertension is characterized by elevated arterial blood pressure due to increased peripheral resistance.
- Abnormal vascular responses, including altered constrictor/dilator activity and vascular remodeling, contribute to this resistance.
Purpose of the Study:
- To review four key cellular signaling pathways implicated in the vascular abnormalities of hypertension.
- To identify novel pharmacological targets for reducing peripheral vascular resistance in hypertensive individuals.
Main Methods:
- This review synthesizes current research on specific cellular signaling pathways.
- Focuses on epidermal growth factor receptor (EGFR), sphingolipid signaling, Rho/Rho kinase (ROCK), and microtubule dynamics.
Main Results:
- Augmented EGFR signaling contributes to cerebrovascular remodeling.
- Reduced sphingolipid signaling impairs vasodilation and promotes smooth muscle proliferation.
- Increased Rho/Rho kinase signaling enhances vasoconstriction.
- Microtubule depolymerization favors vasoconstriction in hypertension.
Conclusions:
- Aberrant signaling through EGFR, sphingolipids, Rho/Rho kinase, and microtubules are critical in hypertension.
- These pathways represent promising targets for developing new antihypertensive therapies.